Haleon
597 hedge funds and large institutions have $5.86B invested in Haleon in 2025 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 193 increasing their positions, 205 reducing their positions, and 55 closing their positions.
229% more call options, than puts
Call options by funds: $1.28M | Put options by funds: $389K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
4% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 55
6% less repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 205
1.8% less ownership
Funds ownership: 8.11% → 6.31% (-1.8%)
2% less funds holding
Funds holding: 609 → 597 (-12)
16% less capital invested
Capital invested by funds: $7.01B → $5.86B (-$1.15B)
Top Buyers
| 1 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
+$76.8M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$75.1M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$47.8M |
| 4 |
Millennium Management
New York
|
+$36.3M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$33.2M |
Top Sellers
| 1 |
P
Pfizer
New York
|
-$1.88B |
| 2 |
Dodge & Cox
San Francisco,
California
|
-$94.4M |
| 3 |
SC
Samlyn Capital
New York
|
-$22.4M |
| 4 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
-$10.4M |
| 5 |
EWA
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
|
-$8.32M |
HLN Hedge Fund Activity: Q1 2025 in Review
597 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Haleon (HLN) for Q1 2025, worth a combined $5.86B — down 16% from $7.01B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of HLN and 53 opened new positions — a net loss of 2 holders — while 205 trimmed existing stakes and 193 added.
The largest buyer was Altshuler Shaham, adding an estimated $76.8M. The largest seller was Pfizer, exiting entirely with an estimated $1.88B sold.
- 597 institutional investors held Haleon (HLN) as of Q1 2025, down from 609 in Q4 2024.
- Funds reported $5.86B of Haleon stock for Q1 2025, down 16% quarter-over-quarter.
- 53 funds opened new Haleon positions in Q1 2025 and 55 closed out, a net change of -2 holders.
- The largest Haleon buyer in Q1 2025 was Altshuler Shaham, an estimated $76.8M added.
- The largest Haleon seller in Q1 2025 was Pfizer, an estimated $1.88B sold.
Based on aggregated 13F filings for Q1 2025.